Literature DB >> 21540571

Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients.

T A Duong1, S Bastuji-Garin, L Valeyrie-Allanore, E Sbidian, S Ferkal, P Wolkenstein.   

Abstract

BACKGROUND: Neurofibromatosis type 1 is fully penetrant by the age of 8 years, and 3 criteria of diagnosis are dermatological: café-au-lait spots (CLS), intertriginous freckling and neurofibromas (NF).
OBJECTIVES: The aim of our study was to determine the evolving pattern of cutaneous manifestations during adulthood.
METHODS: Phenotypic data of patients seen in our center between March 2003 and December 2009 were studied. Patients were classified in 10-year groups. Following clinical characteristics, the number of CLS and the number of cutaneous and subcutaneous NF were compared according to age.
RESULTS: 728 subjects, 404 females and 324 males (mean age of 32.4 years, range 6-80 years) were studied. Four hundred eighty-nine patients were over 20 years old (67%). The number of CLS (small or large) was significantly decreased with age while the number of cutaneous and subcutaneous NF was strongly increased (p < 0.001).
CONCLUSIONS: The decrease in CLS with age has not been previously reported while an increase in the number of NF is well described during puberty and pregnancy and with age.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21540571     DOI: 10.1159/000327379

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  19 in total

1.  The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/- or NF1 -/- genotype derived from human cutaneous neurofibromas.

Authors:  Paula Pennanen; Sirkku Peltonen; Roope A Kallionpää; Juha Peltonen
Journal:  Mol Cell Biochem       Date:  2017-11-28       Impact factor: 3.396

2.  Parents' experiences of caring for a young person with neurofibromatosis type 1 (NF1): a qualitative study.

Authors:  Jenny Barke; Jane Coad; Diana Harcourt
Journal:  J Community Genet       Date:  2015-07-23

3.  Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I.

Authors:  Urania Dagalakis; Maya Lodish; Eva Dombi; Ninet Sinaii; Jessica Sabo; Andrea Baldwin; Seth M Steinberg; Constantine A Stratakis; Brigitte C Widemann
Journal:  J Pediatr       Date:  2013-12-08       Impact factor: 4.406

4.  Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2.

Authors:  Wendy S Vargas; Linda A Heier; Fausto Rodriguez; Amanda Bergner; Kaleb Yohay
Journal:  Neuroimage Clin       Date:  2014-01-04       Impact factor: 4.881

5.  Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.

Authors:  Karin S G Cunha; Rafaela E Rozza-de-Menezes; Raquel M Andrade; Amy Theos; Ronir R Luiz; Bruce Korf; Mauro Geller
Journal:  Orphanet J Rare Dis       Date:  2014-12-05       Impact factor: 4.123

6.  Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Douglas R Stewart; Bruce R Korf; Katherine L Nathanson; David A Stevenson; Kaleb Yohay
Journal:  Genet Med       Date:  2018-04-26       Impact factor: 8.822

7.  Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study.

Authors:  Emilie Sbidian; Smaïl Hadj-Rabia; Vincent M Riccardi; Laurence L Valeyrie-Allanore; Sébastien Barbarot; Olivier Chosidow; Salah Ferkal; Diana Rodriguez; Pierre Wolkenstein; Sylvie Bastuji-Garin
Journal:  Orphanet J Rare Dis       Date:  2012-09-03       Impact factor: 4.123

8.  Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas Into Clinical Research.

Authors:  Deeann Wallis; Anat Stemmer-Rachamimov; Sarah Adsit; Bruce Korf; Dominique Pichard; Jaishri Blakeley; Kavita Y Sarin
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

9.  Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.

Authors:  Ashley Cannon; Dominique C Pichard; Pamela L Wolters; Sarah Adsit; Gregg Erickson; Andrés J Lessing; Peng Li; Whitney Narmore; Claas Röhl; Tena Rosser; Brigitte C Widemann; Jaishri O Blakeley; Scott R Plotkin
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

10.  Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.

Authors:  Sheilagh Maguiness; Yemima Berman; Nathan Rubin; Melissa Dodds; Scott R Plotkin; Claire Wong; Christopher Moertel
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.